Pfizer (PFE) Q2 2017 Results - Earnings Call Transcript

8/2/17

Pfizer Inc. (NYSE:PFE)

Q2 2017 Earnings Call

August 01, 2017 10:00 am ET

Executives

Charles E. Triano - Pfizer Inc.

Ian C. Read - Pfizer Inc.

Frank A. D'Amelio - Pfizer Inc.

John D. Young - Pfizer Inc.

Albert Bourla - Pfizer Inc.

Mikael Dolsten - Pfizer Inc.

Analysts

Gregg Gilbert - Deutsche Bank Securities, Inc.

Jami Rubin - Goldman Sachs & Co. LLC

Alex Arfaei - BMO Capital Markets (United States)

Christopher T. Schott - JPMorgan Securities LLC

Jeffrey Holford - Jefferies LLC

Umer Raffat - Evercore Group LLC

David Maris - Wells Fargo Securities LLC

John T. Boris - SunTrust Robinson Humphrey, Inc.

Timothy Minton Anderson - Sanford C. Bernstein & Co. LLC

Richard J. Purkiss - Piper Jaffray Ltd.

Geoffrey Meacham - Barclays Capital, Inc.

Marc Goodman - UBS Securities LLC

Tony Butler - Guggenheim Securities LLC

David R. Risinger - Morgan Stanley & Co. LLC

Operator

Good day, everyone, and welcome to Pfizer's second quarter 2017 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.

READ FULL ARTICLE HERE